Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MCD
7. MGM
8. NVDA
9. AKAM
10. ACAD

Go back to Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
(NASDAQ: HEPA) Delayed: 0.32 --0 (-0%)
Previous Close $0.32    52 Week High $ 
Open $0.32    52 Week Low $ 
Day High $0.32    P/E N/A 
Day Low $0.32    EPS $ 
Volume 1,060